EU survey on COVID-19 therapeutics

The European Commission’s Task Force for Industrial Scale-Up of COVID-19 Vaccines and Therapeutics has published a survey to understand the needs of the organisations and companies working on the development of compounds in new or repurposed medicines for COVID-19 therapeutics. The purpose of this survey is to support the acceleration of the development and upscale of Covid-19 therapeutics production and shape the support provided by the European Commission.

The European Clusters Alliance, the Council of European BioRegions, and the European Cluster Collaboration Platform are collaborating with the Task Force to spread the survey and to invite relevant organisations and companies to answer the survey.

The questionnaire is directed towards organisations and companies working on the development of compounds in new or repurposed medicines for COVID19 therapeutics. The European Clusters Alliance invites to fill in the survey until 25 June 2021: EU Survey on COVID-19 Therapeutics

All answers will help to pave the way for further support in the develoment of the medicines.